Overall, limited O2 availability and increased HIFα abundance has significant consequences for ERα+ disease by decreasing sensitivity to ER-targeting therapies such as fulvestrant and tamoxifen, disrupting the redox balance and enhancing tumour progression and metastasis. Here, ESR1 is linked to neoplasm.